Announcement
16 Jun 2026
In June 2026, the Nordic Investment Bank (NIB) signed a loan agreement to finance pharmaceutical research and development expenditures.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
16 Jun 2026
Revocation date:
No revocation date
Recent update from 24 Jun 2026:
On 16 June 2026, the Nordic Investment Bank (NIB) signed a EUR 500 (USD 567.34) million loan with Novo Nordisk A/S. The loan will finance pharmaceutical research and development expenditures. The b...
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
71092
194
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7397
152